Primary Antibodies Market Report

Global and Region Primary Antibodies Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：197
  • REPORT CODE：GMM942179
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Primary Antibodies market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Primary Antibodiesmarket, defines the market attractiveness level of Primary Antibodies market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Primary Antibodies industry, describes the types of Primary Antibodies market, the applications of major players and the market size, and deeply analyzes the current situation of the global Primary Antibodies market and the development prospects and opportunities of Primary Antibodies industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Primary Antibodies market in Chapter 13.

    By Player:

    • MABTech

    • KPL

    • CST

    • R&D Systems

    • Bio-Rad

    • BD

    • Abnova

    • AbMax Biotechnology

    • MBL

    • PeproTech

    • Cayman

    • Santa Cruz Biotechnology

    • Thermo Fisher Scientific

    • Sigma Aldrich Corporation

    • Merk

    • Novus Biologicals

    By Type:

    • Polyclonal

    • Monoclonal

    By End-User:

    • ELISA

    • Western Blot

    • Immunostaining

    • Immunohistochemistry

    • Immunocytochemistry

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Primary Antibodies Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Primary Antibodies Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Primary Antibodies Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Primary Antibodies Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Primary Antibodies Market Analysis and Outlook to 2022

    • 7.1 Global Primary Antibodies Consumption (2017-2022)

    • 7.2 United States Primary Antibodies Consumption (2017-2022)

    • 7.3 Europe Primary Antibodies Consumption (2017-2022)

    • 7.4 China Primary Antibodies Consumption (2017-2022)

    • 7.5 Japan Primary Antibodies Consumption (2017-2022)

    • 7.6 India Primary Antibodies Consumption (2017-2022)

    • 7.7 South Korea Primary Antibodies Consumption (2017-2022)

    8 Region and Country-wise Primary Antibodies Market Analysis and Outlook to 2028

    • 8.1 Global Primary Antibodies Consumption Forecast (2022-2028)

    • 8.2 United States Primary Antibodies Consumption Forecast (2022-2028)

    • 8.3 Europe Primary Antibodies Consumption Forecast (2022-2028)

    • 8.4 China Primary Antibodies Consumption Forecast (2022-2028)

    • 8.5 Japan Primary Antibodies Consumption Forecast (2022-2028)

    • 8.6 India Primary Antibodies Consumption Forecast (2022-2028)

    • 8.7 South Korea Primary Antibodies Consumption Forecast (2022-2028)

    9 Global Primary Antibodies Market Outlook by Types and Applications to 2022

    • 9.1 Global Primary Antibodies Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Polyclonal Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Monoclonal Consumption and Growth Rate (2017-2022)

    • 9.2 Global Primary Antibodies Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global ELISA Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Western Blot Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Immunostaining Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Immunohistochemistry Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Immunocytochemistry Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Primary Antibodies Market Outlook by Types and Applications to 2028

    • 10.1 Global Primary Antibodies Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Polyclonal Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Monoclonal Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Primary Antibodies Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global ELISA Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Western Blot Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Immunostaining Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Immunohistochemistry Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Immunocytochemistry Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.6 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Primary Antibodies Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Primary Antibodies Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Primary Antibodies Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Primary Antibodies Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Primary Antibodies Market Competitive Analysis

    • 14.1 MABTech

      • 14.1.1 MABTech Company Details

      • 14.1.2 MABTech Primary Antibodies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 MABTech Primary Antibodies Product and Service

    • 14.2 KPL

      • 14.2.1 KPL Company Details

      • 14.2.2 KPL Primary Antibodies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 KPL Primary Antibodies Product and Service

    • 14.3 CST

      • 14.3.1 CST Company Details

      • 14.3.2 CST Primary Antibodies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 CST Primary Antibodies Product and Service

    • 14.4 R&D Systems

      • 14.4.1 R&D Systems Company Details

      • 14.4.2 R&D Systems Primary Antibodies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 R&D Systems Primary Antibodies Product and Service

    • 14.5 Bio-Rad

      • 14.5.1 Bio-Rad Company Details

      • 14.5.2 Bio-Rad Primary Antibodies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Bio-Rad Primary Antibodies Product and Service

    • 14.6 BD

      • 14.6.1 BD Company Details

      • 14.6.2 BD Primary Antibodies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 BD Primary Antibodies Product and Service

    • 14.7 Abnova

      • 14.7.1 Abnova Company Details

      • 14.7.2 Abnova Primary Antibodies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Abnova Primary Antibodies Product and Service

    • 14.8 AbMax Biotechnology

      • 14.8.1 AbMax Biotechnology Company Details

      • 14.8.2 AbMax Biotechnology Primary Antibodies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 AbMax Biotechnology Primary Antibodies Product and Service

    • 14.9 MBL

      • 14.9.1 MBL Company Details

      • 14.9.2 MBL Primary Antibodies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 MBL Primary Antibodies Product and Service

    • 14.10 PeproTech

      • 14.10.1 PeproTech Company Details

      • 14.10.2 PeproTech Primary Antibodies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 PeproTech Primary Antibodies Product and Service

    • 14.11 Cayman

      • 14.11.1 Cayman Company Details

      • 14.11.2 Cayman Primary Antibodies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Cayman Primary Antibodies Product and Service

    • 14.12 Santa Cruz Biotechnology

      • 14.12.1 Santa Cruz Biotechnology Company Details

      • 14.12.2 Santa Cruz Biotechnology Primary Antibodies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Santa Cruz Biotechnology Primary Antibodies Product and Service

    • 14.13 Thermo Fisher Scientific

      • 14.13.1 Thermo Fisher Scientific Company Details

      • 14.13.2 Thermo Fisher Scientific Primary Antibodies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Thermo Fisher Scientific Primary Antibodies Product and Service

    • 14.14 Sigma Aldrich Corporation

      • 14.14.1 Sigma Aldrich Corporation Company Details

      • 14.14.2 Sigma Aldrich Corporation Primary Antibodies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Sigma Aldrich Corporation Primary Antibodies Product and Service

    • 14.15 Merk

      • 14.15.1 Merk Company Details

      • 14.15.2 Merk Primary Antibodies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Merk Primary Antibodies Product and Service

    • 14.16 Novus Biologicals

      • 14.16.1 Novus Biologicals Company Details

      • 14.16.2 Novus Biologicals Primary Antibodies Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Novus Biologicals Primary Antibodies Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Primary Antibodies

    • Figure Primary Antibodies Picture

    • Table Global Primary Antibodies Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Primary Antibodies Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Primary Antibodies Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Primary Antibodies Consumption by Country (2017-2022)

    • Figure United States Primary Antibodies Consumption and Growth Rate (2017-2022)

    • Table Europe Primary Antibodies Consumption and Growth Rate (2017-2022)

    • Figure China Primary Antibodies Consumption and Growth Rate (2017-2022)

    • Figure Japan Primary Antibodies Consumption and Growth Rate (2017-2022)

    • Figure India Primary Antibodies Consumption and Growth Rate (2017-2022)

    • Figure South Korea Primary Antibodies Consumption and Growth Rate (2017-2022)

    • Figure Global Primary Antibodies Consumption Forecast by Country (2022-2028)

    • Figure United States Primary Antibodies Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Primary Antibodies Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Primary Antibodies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Primary Antibodies Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Primary Antibodies Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Primary Antibodies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Polyclonal Consumption and Growth Rate (2017-2022)

    • Figure Global Monoclonal Consumption and Growth Rate (2017-2022)

    • Figure Global ELISA Consumption and Growth Rate (2017-2022)

    • Figure Global Western Blot Consumption and Growth Rate (2017-2022)

    • Figure Global Immunostaining Consumption and Growth Rate (2017-2022)

    • Figure Global Immunohistochemistry Consumption and Growth Rate (2017-2022)

    • Figure Global Immunocytochemistry Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Polyclonal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Monoclonal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global ELISA Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Western Blot Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immunostaining Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immunohistochemistry Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immunocytochemistry Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Primary Antibodies Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Primary Antibodies Export by Region (Top 5 Countries) (2017-2028)

    • Table MABTech (Foundation Year, Company Profile and etc.)

    • Table MABTech Primary Antibodies Sales, Price, Value and Gross Profit (2017-2022)

    • Table MABTech Primary Antibodies Product and Service

    • Table KPL (Foundation Year, Company Profile and etc.)

    • Table KPL Primary Antibodies Sales, Price, Value and Gross Profit (2017-2022)

    • Table KPL Primary Antibodies Product and Service

    • Table CST (Foundation Year, Company Profile and etc.)

    • Table CST Primary Antibodies Sales, Price, Value and Gross Profit (2017-2022)

    • Table CST Primary Antibodies Product and Service

    • Table R&D Systems (Foundation Year, Company Profile and etc.)

    • Table R&D Systems Primary Antibodies Sales, Price, Value and Gross Profit (2017-2022)

    • Table R&D Systems Primary Antibodies Product and Service

    • Table Bio-Rad (Foundation Year, Company Profile and etc.)

    • Table Bio-Rad Primary Antibodies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bio-Rad Primary Antibodies Product and Service

    • Table BD (Foundation Year, Company Profile and etc.)

    • Table BD Primary Antibodies Sales, Price, Value and Gross Profit (2017-2022)

    • Table BD Primary Antibodies Product and Service

    • Table Abnova (Foundation Year, Company Profile and etc.)

    • Table Abnova Primary Antibodies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abnova Primary Antibodies Product and Service

    • Table AbMax Biotechnology (Foundation Year, Company Profile and etc.)

    • Table AbMax Biotechnology Primary Antibodies Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbMax Biotechnology Primary Antibodies Product and Service

    • Table MBL (Foundation Year, Company Profile and etc.)

    • Table MBL Primary Antibodies Sales, Price, Value and Gross Profit (2017-2022)

    • Table MBL Primary Antibodies Product and Service

    • Table PeproTech (Foundation Year, Company Profile and etc.)

    • Table PeproTech Primary Antibodies Sales, Price, Value and Gross Profit (2017-2022)

    • Table PeproTech Primary Antibodies Product and Service

    • Table Cayman (Foundation Year, Company Profile and etc.)

    • Table Cayman Primary Antibodies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cayman Primary Antibodies Product and Service

    • Table Santa Cruz Biotechnology (Foundation Year, Company Profile and etc.)

    • Table Santa Cruz Biotechnology Primary Antibodies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Santa Cruz Biotechnology Primary Antibodies Product and Service

    • Table Thermo Fisher Scientific (Foundation Year, Company Profile and etc.)

    • Table Thermo Fisher Scientific Primary Antibodies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Thermo Fisher Scientific Primary Antibodies Product and Service

    • Table Sigma Aldrich Corporation (Foundation Year, Company Profile and etc.)

    • Table Sigma Aldrich Corporation Primary Antibodies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sigma Aldrich Corporation Primary Antibodies Product and Service

    • Table Merk (Foundation Year, Company Profile and etc.)

    • Table Merk Primary Antibodies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merk Primary Antibodies Product and Service

    • Table Novus Biologicals (Foundation Year, Company Profile and etc.)

    • Table Novus Biologicals Primary Antibodies Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novus Biologicals Primary Antibodies Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US